143 related articles for article (PubMed ID: 2759546)
21. Hemodynamic effects of oral isosorbide-5-mononitrate and dinitrate in ischemic heart failure.
Rabinowitz B; Hod H; Chouraqui P; Rath S; Agranat O; Neufeld HN
Clin Cardiol; 1987 Oct; 10(10):603-8. PubMed ID: 3665218
[TBL] [Abstract][Full Text] [Related]
22. Propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: long-term hemodynamic and renal effects.
Morillas RM; Planas R; Cabré E; Galán A; Quer JC; Feu F; García Pagán JC; Bosch J; Gassull MA
Hepatology; 1994 Dec; 20(6):1502-8. PubMed ID: 7982651
[TBL] [Abstract][Full Text] [Related]
23. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events].
Castaño G; Viudez P; Sookoian S; Carlevaro O; Riccitelli M; Frider B
Gastroenterol Hepatol; 2000; 23(6):275-81. PubMed ID: 15324622
[TBL] [Abstract][Full Text] [Related]
24. Duplex-Doppler evaluation of the effects of propranolol and isosorbide-5-mononitrate on portal flow and splanchnic arterial circulation in cirrhosis.
Piscaglia F; Gaiani S; Siringo S; Gramantieri L; Serra C; Bolondi L
Aliment Pharmacol Ther; 1998 May; 12(5):475-81. PubMed ID: 9663729
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of captopril and isosorbide mononitrate started early in acute myocardial infarction: a randomized placebo-controlled study.
Pipilis A; Flather M; Collins R; Coats A; Conway M; Appleby P; Sleight P
J Am Coll Cardiol; 1993 Jul; 22(1):73-9. PubMed ID: 8509566
[TBL] [Abstract][Full Text] [Related]
26. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients.
Bolognesi M; Sacerdoti D; Merkel C; Gatta A
J Ultrasound Med; 1994 Dec; 13(12):945-52. PubMed ID: 7877205
[TBL] [Abstract][Full Text] [Related]
27. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone.
Merkel C; Sacerdoti D; Bolognesi M; Enzo E; Marin R; Bombonato G; Angeli P; Gatta A
Hepatology; 1997 Jul; 26(1):34-9. PubMed ID: 9214449
[TBL] [Abstract][Full Text] [Related]
28. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
Nicoll AE; Mackenzie F; Greer IA; Norman JE
Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
[TBL] [Abstract][Full Text] [Related]
29. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
30. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis.
Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ
Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902
[TBL] [Abstract][Full Text] [Related]
31. Clinical vs haemodynamic response to drugs in portal hypertension.
McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
[TBL] [Abstract][Full Text] [Related]
32. Haemodynamic effects of enalaprilat on portal hypertension in patients with HBsAg-positive cirrhosis.
Chiang HT; Cheng JS; Lin M; Tseng WS; Chang JM; Lai KH
J Gastroenterol Hepatol; 1995; 10(3):256-60. PubMed ID: 7548800
[TBL] [Abstract][Full Text] [Related]
33. Haemodynamic interactions between the novel calcium sensitiser levosimendan and isosorbide-5-mononitrate in healthy subjects.
Sundberg S; Lehtonen L
Eur J Clin Pharmacol; 2000; 55(11-12):793-9. PubMed ID: 10805056
[TBL] [Abstract][Full Text] [Related]
34. [Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
Silva G; Fluxá F; Ruiz M; Bresky G; Barrientos C; Backhouse C; Palma M; Iturriaga H
Rev Med Chil; 1993 Aug; 121(8):889-96. PubMed ID: 8296096
[TBL] [Abstract][Full Text] [Related]
35. Treatment of portal hypertension with isosorbide dinitrate alone and in combination with vasopressin.
Hallemans R; Naeije R; Mols P; Mélot C; Reding P
Crit Care Med; 1983 Jul; 11(7):536-40. PubMed ID: 6861502
[TBL] [Abstract][Full Text] [Related]
36. [The use of oral and intravenous isosorbide mononitrate (5-MNi) in the acute phase of myocardial infarction].
Rezende M
Rev Port Cardiol; 1993 Mar; 12 Suppl 1():I35-8. PubMed ID: 8499118
[TBL] [Abstract][Full Text] [Related]
37. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
Bolognesi M; Sacerdoti D; Merkel C; Caregaro L; Bellon S; Gatta A
Bildgebung; 1995 Jun; 62(2):138-43. PubMed ID: 7663138
[TBL] [Abstract][Full Text] [Related]
38. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin.
Bosch J; Kravetz D; Rodes J
Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897
[TBL] [Abstract][Full Text] [Related]
39. Acute effect of propranolol and isosorbide-5-mononitrate administration on renal blood flow in cirrhotic patients.
Stanley AJ; Bouchier IA; Hayes PC
Gut; 1998 Feb; 42(2):283-7. PubMed ID: 9536956
[TBL] [Abstract][Full Text] [Related]
40. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis.
Villanueva C; López-Balaguer JM; Aracil C; Kolle L; González B; Miñana J; Soriano G; Guarner C; Balanzó J
J Hepatol; 2004 May; 40(5):757-65. PubMed ID: 15094222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
